Mitsubishi Gas Chemical Company (4182) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
7 Aug, 2026Executive summary
Net sales for FY2026 1Q rose to ¥223.7bn, up 25.7% year-over-year, driven by higher methanol prices, strong electronics materials sales, and yen depreciation.
Operating profit surged to ¥27.8bn, up 153.5% year-over-year, supported by inventory gains, favorable market conditions, and gains in basic chemicals and engineering plastics.
Ordinary profit reached ¥29.1bn, up 111.0% year-over-year, despite a decline in equity in earnings of affiliates due to Middle East disruptions.
Profit attributable to owners of parent increased to ¥18.3bn, up 118.1% year-over-year.
Comprehensive income soared 330.0% year-over-year to ¥29.2bn.
Financial highlights
Gross profit increased to ¥56.4bn from ¥39.3bn year-over-year.
EPS for 1Q was ¥94.02, compared to ¥43.17 in the prior year.
Equity ratio stood at 57.4% as of June 30, 2026.
Total assets increased to ¥1,159.2bn as of June 30, 2026.
EBITDA forecast for FY2026 is ¥122.8bn.
Outlook and guidance
Full-year FY2026 net sales forecast revised up to ¥860.0bn, operating profit to ¥71.0bn, and profit attributable to owners of parent to ¥55.0bn.
Annual dividend planned at ¥110 per share, a ¥10 increase from FY2025.
2Q net sales and operating profit expected to decline sequentially due to lower methanol prices and inventory losses.
2H profit expected to decrease due to regular maintenance and temporary cost increases.
Profit attributable to owners of parent forecast with EPS of ¥282.04.
Latest events from Mitsubishi Gas Chemical Company
- Structural reforms and ICT investments drive profit recovery and higher dividends in FY2026.4182
Investor presentation - FY2026 is set for strong profit recovery after FY2025's net loss and impairment charges.4182
Q4 2026 - Operating profit more than doubled on strong specialty chemicals demand and yen depreciation.4182
Q1 2025 - Operating profit surged 52.7% year-over-year, driven by Specialty Chemicals growth.4182
Q2 2025 - Operating profit rose 17.2% despite lower sales, driven by Specialty Chemicals and yen effects.4182
Q3 2025 - Operating profit up 7.4% despite 4.9% sales drop; FY2025 outlook cautious.4182
Q4 2025 - Profits fell on weak chemical markets and FX volatility, but sales forecast was raised.4182
Q1 2026 - Impairment loss and weak markets drive lower profits and a revised net loss outlook for FY2025.4182
Q2 2026 - Profits fell on lower prices and impairments, but dividend forecast raised to ¥100 per share.4182
Q3 2026